Patient & Survivor Care
From the Journals
Adjuvant Everolimus Offers No Survival Benefit in Non–Clear Cell RCC
Researchers evaluated everolimus in the adjuvant setting in patients with either clear cell or non–clear cell RCC at a high risk for recurrence...
From the Journals
SBRT vs Surgery in CRC Lung Metastases: Which Is Better?
Researchers compared outcomes among 335 patients with lung metastases from CRC who underwent surgery or SBRT.
From the Journals
Cancer Cases, Deaths in Men Predicted to Surge by 2050
Researchers analyzed data from the 2022 Global Cancer Observatory (GLOBOCAN), which provides national-level estimates for cancer cases and deaths...
From the Journals
Aspirin for CRC Prevention May Work Best in Adults With Unhealthy Lifestyles
Researchers analyzed regular aspirin use based on data from more than 100,000 individuals.
Feature
Patient Navigators for Serious Illnesses Can Now Bill Under New Medicare Codes
New Medicare codes will enable physicians to hire navigators to help patients manage serious illnesses such as cancer and heart failure.
Latest News
Unseen Toll: Cancer Patients’ Spouses Face Higher Suicide Risk
“These findings suggest a need for clinical and societal awareness to prevent suicidal behaviors among spouses of patients with cancer.”
Feature
Could Baseline MRIs Reshape Prostate Cancer Risk Assessment?
Investigators analyzed data from men with prostate cancer who had MRI within 6 months before or after their initial biopsy.
Feature
Liposomal Irinotecan May Be Effective in Later Lines for Pancreatic Cancer
Real-world meta-analysis finds benefit of later-line liposomal irinotecan is not attenuated by prior conventional irinotecan.
Commentary
Cancer Treatment 101: A Primer for Non-Oncologists
Doctor explains why he thinks time of diagnosis is the best time for molecular testing of a new malignant tumor.
From the Journals
Can Belzutifan Improve Outcomes in Advanced RCC?
Researchers compared the efficacy and safety of belzutifan with everolimus in patients with advanced clear cell renal cell carcinoma.
Feature
Should All Patients With Early BC Receive Adjuvant Radiotherapy?
Researchers analyze data from a trial of 589 patients with early breast cancer, who were randomized to receive either high-dose or no radiotherapy...